MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹4.56 Cr | ₹3.25 Cr | ₹1.86 Cr | ₹2.11 Cr | ₹1.48 Cr |
What is the latest Long Term Provisions ratio of MARKSANS PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹4.56 Cr |
Mar2023 | ₹3.25 Cr |
Mar2022 | ₹1.86 Cr |
Mar2021 | ₹2.11 Cr |
Mar2020 | ₹1.48 Cr |
How is Long Term Provisions of MARKSANS PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹4.56 Cr | 40.19 | |
Mar2023 | ₹3.25 Cr | 75.22 | |
Mar2022 | ₹1.86 Cr | -12.08 | |
Mar2021 | ₹2.11 Cr | 43.12 | |
Mar2020 | ₹1.48 Cr | - |
Compare Long Term Provisions of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹9,118.4 Cr | 1.1% | -26.3% | 34.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1.1% |
-26.3% |
34.1% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses